David Parker, PhD
Articles
CMS to Cover Next-Gen Sequencing for Cancer: Implications for MCOs
June 1st 2018In a decision reached through the joint FDA/CMS Parallel Review process, CMS has granted national Medicare coverage to next-generation sequencing tests approved or cleared by the FDA as companion diagnostics for cancer therapies. This is clearly a win for Medicare beneficiaries and some NGS test providers-but is it also good news for MCOs?
Read More
Latest Updated Articles
Published: December 10th 2024 | Updated: December 22nd 2024
Next-Generation Testing Cheaper and More Effective for Guiding Lung Cancer Treatment
Published: July 20th 2020 | Updated: December 22nd 2024
For Better HCQ Retinopathy Guidelines, Include Prescribing Physicians
Published: October 3rd 2024 | Updated: December 22nd 2024
K-Cast Written Summary. Diabetes Quality Measures Have Challenges But Also Successes
Published: October 7th 2024 | Updated: December 22nd 2024
K-Cast Written Summary. Key Patient Considerations for Use of Intravenous and Subcutaneous Therapies
Published: November 7th 2024 | Updated: December 22nd 2024
K-Cast Written Summary. Optimizing the Management of Myelofibrosis
Published: July 11th 2024 | Updated: December 22nd 2024
K-Cast Written Summary. FDA-Approved Treatment for Demodex Bepharitis Shortens Treatment, Improves Quality of Life
